Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
4.670
+0.090 (1.97%)
At close: Jun 18, 2026, 4:00 PM EDT
4.700
+0.030 (0.64%)
After-hours: Jun 18, 2026, 7:53 PM EDT
Cybin Market Cap
Cybin has a market cap or net worth of $233.67 million as of June 18, 2026. Its market cap has increased by 29.46% in one year.
Market Cap
233.67M
Enterprise Value
38.54M
1-Year Change
29.46%
Ranking
Category
Stock Price
$4.67
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $233.67M, an increase of 156.51%. That is a compound annual growth rate of 18.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 233.67M | -42.76% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fate Therapeutics | 243.61M |
| Sol-Gel Technologies | 243.41M |
| Orchestra BioMed Holdings | 238.92M |
| AC Immune | 238.08M |
| Whitehawk Therapeutics | 237.72M |
| Canton Strategic Holdings | 233.85M |
| NervGen Pharma | 233.65M |
| Codexis | 233.60M |